CLINICAL_TRIALS
trial_result
· 2019-04-26
Clinical Trial Update: Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid Spasm [Phase 4]
Summary
Phase 4 clinical trial comparing pretarsal vs preseptal botulinum toxin for eyelid spasm has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The University of Hong Kong | Conditions: Blepharospasm, Hemifacial Spasm | Phase 4 | Status: COMPLETED